Hypofractionated Radiation Therapy: A Potential Option for Advanced Intrahepatic Cholangiocarcinoma

被引：0
|
作者：
Shindoh, Junichi [1 ]
机构：
[1] Toranomon Gen Hosp, Dept Surg Gastroenterol, Hepatobiliary Surg Div, Tokyo, Japan
来源：
ANNALS OF SURGICAL ONCOLOGY | 2020年 / 27卷 / 04期
关键词：
HEPATOCELLULAR-CARCINOMA; SURVIVAL;
D O I：
10.1245/s10434-019-08145-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：983 / 984
页数：2
相关论文
共 50 条
  • [21] Inflammatory markers in intrahepatic cholangiocarcinoma: Effects of advanced liver disease
    Sellers, Cortlandt M.
    Uhlig, Johannes
    Ludwig, Johannes M.
    Stein, Stacey M.
    Kim, Hyun S.
    CANCER MEDICINE, 2019, 8 (13): : 5916 - 5929
  • [22] Intrahepatic cholangiocarcinoma: Evolving role of neoadjuvant and targeted therapy
    Ghio, Michael
    Vijay, Adarsh
    ANNALS OF HEPATO-BILIARY-PANCREATIC SURGERY, 2023, 27 (02) : 123 - 130
  • [23] Intrahepatic cholangiocarcinoma in a transplant liver - selective internal radiation therapy followed by right hemihepatectomy: report of a case
    Sperling, Jens
    Justinger, Christoph
    Schuld, Jochen
    Ziemann, Christian
    Seidel, Roland
    Kollmar, Otto
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2014, 12
  • [24] Proton beam therapy for intrahepatic cholangiocarcinoma: A multicenter prospective registry study in Japan
    Mizumoto, Masashi
    Terashima, Kazuki
    Makishima, Hirokazu
    Suzuki, Motohisa
    Ogino, Takashi
    Waki, Takahiro
    Iwata, Hiromitsu
    Tamamura, Hiroyasu
    Uchinami, Yusuke
    Akimoto, Tetsuo
    Okimoto, Tomoaki
    Iizumi, Takashi
    Murakami, Masao
    Katoh, Norio
    Maruo, Kazushi
    Shibuya, Kei
    Sakurai, Hideyuki
    LIVER CANCER, 2024, 13 (02) : 161 - 168
  • [25] Multimodal Therapy including Yttrium-90 Radioembolization as a Bridging Therapy to Liver Transplantation for a Huge and Locally Advanced Intrahepatic Cholangiocarcinoma
    Rayar, Michel
    Sandri, Giovanni Battista Levi
    Houssel-Debry, Pauline
    Camus, Christophe
    Sulpice, Laurent
    Boudjema, Karim
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2016, 25 (03) : 401 - 404
  • [26] Magnetic resonance image-guided hypofractionated ablative radiation therapy for extrahepatic cholangiocarcinoma: Plan adaptation in changing anatomy
    Egriboyun, Sebnem
    Ugurluer, Gamze
    Gungor, Gorkem
    Mustafayev, Teuta Zoto
    Cicek, Bahattin
    Demir, Gokhan
    Atalar, Banu
    Ozyar, Enis
    MEDICAL DOSIMETRY, 2021, 46 (04) : 435 - 439
  • [27] Combination of TACE and Lenvatinib as a promising option for downstaging to surgery of initially unresectable intrahepatic cholangiocarcinoma
    Peng Yuan
    Jinhua Song
    Fei Wang
    Guangyu Zhu
    Baoan Chen
    Investigational New Drugs, 2022, 40 : 1125 - 1132
  • [28] Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma
    Gkika, Eleni
    Hallauer, Lukas
    Kirste, Simon
    Adebahr, Sonja
    Bartl, Nico
    Neeff, Hannes Philipp
    Fritsch, Ralph
    Brass, Volker
    Nestle, Ursula
    Grosu, Anca Ligia
    Brunner, Thomas Baptist
    BMC CANCER, 2017, 17
  • [29] Extreme hypofractionated radiation therapy for pancreatic cancer
    Rouffiac, M.
    Ghirardi, S.
    Chevalier, C.
    Bessieres, I
    Peignaux-Casasnovas, K.
    Truc, G.
    Crehange, G.
    CANCER RADIOTHERAPIE, 2021, 25 (6-7): : 692 - 698
  • [30] Molecular signatures of intrahepatic cholangiocarcinoma: role in targeted therapy selection
    Glushko, Tetiana
    Costello, James
    Chima, Ranjit
    McGettigan, Melissa
    Kim, Richard
    Jeong, Daniel
    Qayyum, Aliya
    EUROPEAN JOURNAL OF RADIOLOGY, 2025, 187
12345